In honor of Craig M. Crews, who is a professor at Yale in the fields of chemistry, pharmacology, and management, in addition to serving as the John C. Malone Professor of Molecular, Cellular, and Developmental Biology, he was awarded the 2022 Connecticut Medal of Technology on May 13, according to an announcement made by the Connecticut Academy of Science and Engineering (CASE).
Crews will be presented with his award on May 26th at the CASE annual meeting. The Connecticut Center for Advanced Technology (CCAT) will also be awarded a medal (CCAT).
His groundbreaking study on targeted protein degradation led to the development of a new pharmaceutical sector, which was awarded the Nobel Prize in chemistry (TPD). The biotech firm Proteolix was created in 2003 by Crews and Raymond Deshaies, who is currently a senior vice president at Amgen. There is a new treatment for multiple myeloma that was developed by Proteolix. In 2012, the FDA approved the therapy for use in the United States.
The Connecticut Medal of Technology is given to individuals, teams, companies, and nonprofits who have made outstanding contributions to Connecticut’s and the nation’s economic, environmental, and social well-being by promoting technology, innovating in the field of technology, or developing the technological workforce.
On behalf of the whole state, I want to thank Professor Crews and Ron Angelo and his staff at CCAT for contributing to making Connecticut the great state we know it — and congratulate them both on winning Connecticut’s highest accolade for technological achievement,” stated Connecticut Gov. Ned Lamont.